Antifungal Agents
DOI: 10.1385/1-59259-943-5:143
|View full text |Cite
|
Sign up to set email alerts
|

Antifungal Combinations

Abstract: The increase in fungal infections and the change in fungal epidemiology is caused by the extensive use of antifungal agents to treat fungal infections that are being diagnosed in severly immunocompromised hosts. In addition, opportunistic fungal infections resistant to antifungal drugs have become increasingly common, and the armamentarium for treatment remains limited. A possible approach to overcoming these problems is to combine antifungal drugs, especially if the mechanisms of action are different. The in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
64
0

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 47 publications
(65 citation statements)
references
References 0 publications
1
64
0
Order By: Relevance
“…Assays were performed in flat-bottomed 96-well microtitration plates using the chequerboard method (Vitale et al 2005). C. krusei was used at a final concentration of 0.5-2.5 x 10 5 CFU/mL.…”
Section: Interaction Of Essential Oils and Drugsmentioning
confidence: 99%
See 1 more Smart Citation
“…Assays were performed in flat-bottomed 96-well microtitration plates using the chequerboard method (Vitale et al 2005). C. krusei was used at a final concentration of 0.5-2.5 x 10 5 CFU/mL.…”
Section: Interaction Of Essential Oils and Drugsmentioning
confidence: 99%
“…The final concentrations of the itraconazole and amphotericin B ranged from 0.004 to 2 μg/ mL and the essential oil of C. ambrosioides L.from 0.488 to 31.25 μg/mL. The fractional inhibitory index (FICI) was calculated and the interpretation was determined as follow: ≤0.5 Synergistic effect; >0.5 but <4, no interaction; and ≥4 antagonistic effect (Vitale et al 2005).…”
Section: Interaction Of Essential Oils and Drugsmentioning
confidence: 99%
“…Cell numbers of zoospores were counted on a hemocytometer; zoospores were diluted in RPMI 1640 containing L-glutamine and buffered to pH 7.0 with 0.165 M MOPS (morpholinepropanesulfonic acid) to obtain a final concentration range of 2 ϫ 10 3 to 3 ϫ 10 3 zoospores/ml (10). The combinations of TRB (Novartis) plus CAS (Merck), TRB plus MNZ (Labware), TRB plus ketoconazole (Janssen), and TRB plus FLC (Pfizer) were evaluated using the checkerboard technique, according to the broth microdilution design (2,14). In the individual tests, 100 l of each drug concentration was plated in microplate wells and an equal volume of the inoculum was added to each well.…”
mentioning
confidence: 99%
“…Treatment using combinations of different antifungal drugs has been suggested to address the development of resistance among pathogens, as well as to reduce side effects due to drug toxicity to the patient and to achieve antimicrobial synergy (68). Combination treatments are widely used for treating aspergillosis as well as other infections (69).…”
Section: Figmentioning
confidence: 99%